Pertussis epidemiology in Argentina trends over 2004-2007

HOZBOR DANIELA; MOOI F. R.; FLORES DARÍO; WELTMAN GABRIELA; BOTTERO DANIELA; FOSSATI S.; LARA CLAUDIA; GAILLARD M. EMILIA; PIANCIOLA LUIS; ZURITA EUGENIA; FIORITTI ARIEL; ARCHUBY DANIELA; GALAS M.; BINSZTEIN NORMA; REGUEIRA MABEL; CASTUMA CELINA; FINGERMANN MATÍAS; GRAIEB AUGUSTO

J. Infect

Elsevier

Año: 2009 vol. 59 p. 225 - 231

OBJECTIVES: Pertussis continues causing significant morbidity and mortality worldwide. Although its epidemiology has been studied in many developed countries, the current pertussis situation in South America is scarcely known. This review summarizes the most important recent data concerning pertussis in a country of South America, Argentina. METHODS: CDC criteria were used for pertussis diagnosis. Proportion of pertussis cases by age, immunization status, and immunization coverage rate evaluated at the Argentinean National Pertussis Reference Centers was reported. Bordetella pertussis isolates were characterized and compared with vaccine strains. RESULTS: From 2002 to nowadays, a steady increase of pertussis cases was observed. Most of these cases correspond to patients younger than six months old that received less than three doses of vaccine. However, cases in adolescent and adults have also been detected. For this situation, which is not peculiar to Argentina, several explanations have been proposed. Among them, the inability of current vaccines to induce long-lasting immunity is the most widely accepted as a cause of pertussis resurgence. Furthermore, antigenic divergence between local clinical isolates and vaccine strains may have aggravated the effect of waning immunity. CONCLUSIONS: Pertussis is an important problem for public health in Argentina. Divergence between vaccine strains and local isolates could contribute to the described pertussis epidemiology.